[1] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
|
[2] |
Shimakawa Y, Yan HJ, Tsuchiya N, et al. Association of early age at establishment of chronic hepatitis B infection with persistent virus replication, liver cirrhosis and hepatocellular carcinoma: a systematic review[J]. PLoS One, 2013, 8(7):e69430.
|
[3] |
Kawanishi S, Ohnishi S, Ma N, et al. Nitrative and oxidative DNA damage in infection-related carcinogenesis in relation to cancer stem cells[J]. Genes Environ, 2017(39):8.
|
[4] |
中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24.
|
[5] |
中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
[6] |
Rajasekaran D, Elavarasan J, Sivalingam M, et al. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats[J]. Mol Med Rep, 2011, 4(6):1211-1217.
|
[7] |
Chang W, He W, Li PP, et al. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms[J]. Eur J Pharmacol, 2016, 784(5):173-180.
|
[8] |
Ohnishi S, Ma N, Thanan R, et al. DNA damage in inflammation-related carcinogenesis and cancer stem cells[J]. Oxid Med Cell Longev, 2013:387014.
|
[9] |
Gerić M, Gajski G, Garaj-Vrhovac V. γ-H2AX as a biomarker for DNA double-strand breaks in ecotoxicology[J]. Ecotoxicol Environ Saf, 2014, 105:13-21.
|
[10] |
Ivashkevich A, Redon CE, Nakamura AJ, et al. Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research[J]. Cancer Lett, 2012, 327(1/2):123-133.
|
[11] |
Shah K, Cornelissen B, Kiltie AE, et al. Can γH2AX be used to personalise cancer treatment?[J]. Curr Mol Med, 2013, 13(10):1591-1602.
|
[12] |
Fedeles BI, Freudenthal BD, Yau E, et al. Intrinsic mutagenic properties of 5-chlorocytosine: a mechanistic connection between chronic inflammation and cancer[J]. Proc Natl Acad Sci U S A, 2015, 112(33):E4571-4580.
|
[13] |
Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, et al. Clinical and pathological factor associated with the development of hepatocellular carcinoma in patients with hepatities virus-related cirrhosis: a long-term follow-up study[J]. Clin Oncol, 2007, 19(3):197-203.
|
[14] |
Aleksandrova K, Boeing H, Nöthlings U, et al. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer[J]. Hepatology, 2014, 60(3):858-871.
|
[15] |
Sunami Y, Ringelhan M, Kokai E, et al. Canonical NF-kB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded response[J]. Hepatology, 2016, 63(5):1592-1607.
|
[16] |
Liu M, Duke JL, Richter DJ, et al. Two levels of protection for the B cell genome during somatic hypermutation[J]. Nature, 2008, 451(7180):841-845.
|
[17] |
Wan S, Zhao E, Kryczek I, et al. Tumor-associated macrophages produce interleukin 6 and via STAT3 to promote expansion of human hepatocellular carcinoma stem cells[J]. Gastroenterology, 2014, 147(6):1393-1404.
|
[18] |
Galdiero MR, Bonavita E, Barajon I, et al. Tumor associated macrophages and neutrophils in cancer[J]. Immunobiology, 2013, 218(11):1402-1410.
|
[19] |
姜楠,阮丹云,李洋,等.人肝癌干细胞生物学行为的实验研究[J/CD].中华肝脏外科手术学电子杂志,2014,3(1):41-44.
|
[20] |
詹世淮,雷艳,黄梁浒,等.三维细胞培养技术应用于肿瘤细胞的研究进展[J/CD].中华细胞与干细胞杂志(电子版),2016,6(4):248-251.
|